The FDA has been busy so far in 2014, with a raft of new guidances and proposals with important implications for companies developing new medical devices and digital health products.
MASSDEVICE ON CALL — The FDA released a spate of new guidances in the 1st half of 2014, several with important implications for medical device and digital health companies.
Law360.com picked out some of the highlights from the year, including measures that affect how healthcare companies can communicate over social media and new rules that relax oversight of healthcare data systems and clinical decision software.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oKmlyU
Cap comentari:
Publica un comentari a l'entrada